Core Viewpoint - Jiangsu Qingquan Chemical Co., Ltd. has applied for a change in its listing review status to "inquired" on the Shenzhen Stock Exchange's ChiNext, aiming to raise 492.3 million yuan [1] Company Overview - Qingquan Co. specializes in the R&D, production, and sales of specialty fine chemicals and high-performance polymer materials, recognized as a national-level "little giant" enterprise focusing on advanced polymer materials and non-grain bio-based materials [1] - The company has developed a product system that includes new material monomers, green solvents, pharmaceutical and pesticide intermediates, and specialty polymer materials, with applications in various sectors such as aerospace, wind power, automotive, electronics, medical devices, chemicals, pharmaceuticals, and pesticides [1] Product and Market Position - The core products, including the new material monomer MACM and green solvent 2-MeTHF, have achieved high industry standards and are competitive against major industry players [2] - The global market share for MACM is estimated at 28% and for 2-MeTHF at 19% for the year 2024 [2] - The company has established partnerships with well-known domestic and international clients, including Zhangye Dagong, Grida Group, and Sinopec [2] Fundraising and Investment Plans - The funds raised from the IPO will be allocated to projects related to the company's main business, including the production of 5,000 tons of MACM and 4,000 tons of THF, as well as the construction of a research and development center [3] Financial Performance - Revenue for the years 2022, 2023, 2024, and the first half of 2025 is projected to be approximately 687 million yuan, 713 million yuan, 797 million yuan, and 396 million yuan respectively [3] - Net profit for the same periods is expected to be around 52.83 million yuan, 81.82 million yuan, 98.66 million yuan, and 57.91 million yuan [4] - Total assets and equity attributable to shareholders have shown fluctuations, with total assets at 1.023 billion yuan and equity at 706.95 million yuan as of June 30, 2025 [5]

Core Viewpoint - 聚维元创 is making significant strides in the non-grain biomass sector, focusing on innovative products and sustainable practices, highlighted by its ISCC PLUS certification and participation in the 2026 DT New Leaf Award [2][5][24]. Group 1: Certification and Recognition - 聚维元创 has successfully obtained ISCC PLUS certification, becoming the first company globally to focus on non-grain bio-based succinic acid and achieve this certification [2][5]. - The company has two cases selected as typical examples by the Ministry of Industry and Information Technology and the Ministry of Agriculture and Rural Affairs, showcasing its technological innovation and application in non-grain bio-based materials [9][10]. Group 2: Technological Advancements - The first selected case involves a technology for producing succinic acid from straw, which significantly reduces production costs and carbon emissions by over 75% compared to traditional petrochemical methods [10]. - The second case focuses on utilizing by-products from brewing to create high-performance materials, achieving over 70% carbon reduction [11]. Group 3: Capacity Expansion - 聚维元创 raised nearly 500 million yuan in its Pre-B4 financing round, facilitating the establishment of a 100,000-ton production capacity [13]. - The company has launched a 50,000-ton straw-based bio-manufacturing base in Liaocheng, with another base in Lianyungang nearing completion, expected to be operational by mid-2026 [13]. Group 4: Industry Ecosystem - 聚维元创 is forming strategic partnerships across various sectors, including a collaboration with 亚香股份 in the fragrance industry to promote sustainable manufacturing [14]. - In the bio-based materials sector, a partnership with 利夫生物 aims to create a complete industrial chain from non-grain biomass to high-performance materials [15]. Group 5: Platform and Events - At the 10th Bio-based Conference, 聚维元创 launched its straw-based bio-manufacturing flexible platform and offered free samples for public testing [17][19]. - The company received the "Most Commercially Valuable Award" at the 2025 New Leaf Award for its innovative platform that integrates enzyme engineering and AI [21].

Core Viewpoint - Jiangsu Qingquan Chemical Co., Ltd. (Qingquan) plans to raise 492 million yuan through its IPO on the ChiNext board, with nearly 40% of its revenue coming from non-grain bio-based products, and a comprehensive gross profit margin of 30.22% [2][18]. Group 1: Company Overview - Qingquan is a national-level specialized and innovative "little giant" enterprise focused on the R&D, production, and sales of specialty fine chemicals and high-performance polymer materials [6]. - The company has developed a product system that includes new material monomers, green solvents, pharmaceutical and pesticide intermediates, and specialty polymer materials, widely applied in various sectors such as aerospace, wind power, automotive, electronics, medical devices, chemicals, pharmaceuticals, and pesticides [6]. Group 2: Financial Performance - From 2022 to 2024, Qingquan's revenue increased from 687 million yuan to 797 million yuan, with a compound annual growth rate of approximately 7.5% [21]. - The net profit attributable to the parent company surged from 19.96 million yuan to 91.05 million yuan, a growth of 4.6 times [21]. - The comprehensive gross profit margin improved from 23.65% in 2022 to 30.22% in 2024, indicating strong profitability driven by product structure optimization and cost control [21][22]. Group 3: Product and Market Insights - Qingquan's bio-based products include DTHFP, 2-MeTHF, and CPMK, with 2-MeTHF holding a 19% share of the global market [8][18]. - The global market for 2-MeTHF is projected to reach approximately 137 million USD in 2024, with an annual compound growth rate exceeding 20% from 2023 to 2027 [13]. - The company has established a competitive edge through its high-pressure catalytic hydrogenation technology, which enhances production efficiency and product purity [15][20]. Group 4: Investment and Future Prospects - The IPO proceeds will primarily fund the expansion of bio-based THF production capacity from 400 tons per year to 3,000 tons per year, with an investment of 130 million yuan [23]. - The bio-based materials industry is expected to accelerate from 2025 to 2030, driven by increasing policy pressures such as carbon taxes and ESG considerations [24]. - Qingquan's case illustrates that the key to the industrialization of non-grain bio-based materials lies not only in raw material supply but also in the ability to develop high-value downstream products [25].

Core Viewpoint - Jiangsu Qingquan Chemical Co., Ltd. (referred to as "Qingquan") is advancing its IPO on the ChiNext board, aiming to raise 492 million yuan for various projects [1] Company Overview - Qingquan specializes in the R&D, production, and sales of specialty fine chemicals and high-performance polymer materials, recognized as a national-level "little giant" enterprise focusing on specialized technologies [3] - The company has developed a product matrix that includes new material monomers, green solvents, pharmaceutical and pesticide intermediates, and specialty polymer materials, with applications in aerospace, wind power, automotive, electronics, medical devices, chemicals, pharmaceuticals, and pesticides [3] - Qingquan is one of the early adopters in China to develop non-grain biomass-based raw materials, specifically furfural, breaking the traditional reliance on petroleum-based products [3] Technical Capabilities - Qingquan is recognized for its large-scale application of high-pressure catalytic hydrogenation technology in the fine chemical sector and has been designated as a "High-Pressure Catalytic Hydrogenation Engineering Technology Research Center" by the Jiangsu Provincial Department of Science and Technology [4] - The company has achieved international advanced levels in the development and industrialization of selective catalytic hydrogenation technology for cyclic specialty monomers, with its six-membered aromatic ring hydrogenation catalyst and process being internationally leading [4] - Qingquan's core products, MACM and 2-MeTHF, hold approximately 28% and 19% of the global market share, respectively, indicating a strong competitive position in the industry [4] Financial Performance - From 2022 to the first half of 2025, Qingquan's revenue is projected to grow from 687 million yuan to 797 million yuan, with net profits increasing from 53 million yuan to 99 million yuan [5] - The funds raised from the IPO will be allocated to projects including the technical transformation of MACM production, the production of furfural, tetrahydrofuran, and the establishment of a research and development center [5]

Core Viewpoint - Yinuo Biotech, a company focused on converting non-grain biomass waste into valuable products, recently listed on the National Equities Exchange and Quotations (NEEQ) on December 22, 2023, and has been recognized as a typical case of innovation in the non-grain bio-based materials industry by the Ministry of Industry and Information Technology [1][10]. Company Overview - Established in 2015, Yinuo Biotech specializes in the research, production, and sales of bio-based furan series and bio-based polyol series products [3][11]. - The company primarily utilizes corn cobs as a raw material, achieving a 98% raw material conversion rate, significantly higher than the industry average of 85%, and increasing the value of corn cobs by 300% per ton [5][13]. Product Details - Key products include furfural alcohol and 2-methyl tetrahydrofuran (2-MeTHF), with furfural alcohol recognized as a national manufacturing single champion product, essential for synthetic resins, coatings, and pharmaceutical intermediates [5][13]. - 2-MeTHF is acknowledged as a provincial manufacturing single champion product in Shandong, serving as an important eco-friendly solvent and chemical intermediate widely used in pharmaceuticals, electronic chemicals, and coatings [5][13]. Financial Performance - For the fiscal year 2024, Yinuo Biotech reported revenues of 944.51 million yuan and a net profit of 104.49 million yuan, with a gross margin of 20.8% [6][14]. - The company's revenue for the first four months of 2025 is projected at 370.08 million yuan, with a net profit of 55.69 million yuan [6][14]. - The decline in main business performance is attributed to a decrease in average sales prices of key products like furfural alcohol and 2-MeTHF [6][14]. Market Position and Relationships - Yinuo Biotech has established long-term stable partnerships with notable companies such as Kao Corporation, Yangnong Chemical, and Jinan Shengquan, gaining widespread recognition from downstream customers [6][14]. Industry Trends - The bio-based materials market in China has grown from 13.511 billion yuan in 2016 to 42.961 billion yuan in 2023, with a strong growth forecast as 35% of petrochemical and coal chemical products are expected to be replaced by bio-manufactured products in the next decade [7][15]. - The "14th Five-Year Plan" for bio-economy development predicts robust growth in the bio-based materials sector, supported by government initiatives aimed at promoting innovation in non-grain biomass materials [7][15]. Recent Developments - In December 2023, the Ministry of Industry and Information Technology released typical cases of innovation in the non-grain bio-based materials industry, aiming to enhance the collection and transportation of non-grain biomass [9][17]. - Yinuo Biotech announced on December 25, 2023, that the Shandong Securities Regulatory Bureau accepted its application for listing guidance on the Beijing Stock Exchange, with Guotou Securities as the advisory institution [9][17].

Core Insights - The article discusses the emerging non-grain bio-based materials industry in China, highlighting its potential to transform agricultural waste into valuable products, such as biodegradable plastics and biofuels, which are crucial for the green transition [2][6][20] Industry Overview - The Ministry of Industry and Information Technology (MIIT) released a list of 35 projects from 12 provinces, with Shandong and Anhui leading in the number of entries [2] - The non-grain bio-based materials market in China is projected to exceed 120 billion yuan by 2025, with an annual growth rate of 18.7% and a raw material substitution rate reaching 40% [2][6] Historical Context - The industry's roots trace back to the oil crisis of the late 1970s, which prompted countries to seek alternatives to fossil fuels [3][4] - The shift from fossil-based to bio-based materials is driven by the need for sustainable and renewable resources [5] Technological Advancements - China has surpassed the U.S. in the scale of bio-based materials production, focusing on agricultural waste like straw and corn husks instead of food crops [6][7] - The development of high-yield industrial strains for non-grain bio-based materials is exemplified by Wuhan Ruijia Kang Biotechnology Co., which has developed technology to convert agricultural waste into ethanol [16][20] Regional Developments - Anhui and Henan provinces are at the forefront of the non-grain bio-based materials industry, with specific counties recognized for their contributions [8][13] - Nale County in Henan has become a core production base for biodegradable plastics, while Guzhen County in Anhui focuses on textiles and nutritional additives [10][12] Market Dynamics - The global bio-based plastic capacity is expected to reach 2.47 million tons by 2024, with significant demand in packaging and textile industries [8] - The competitive landscape is evolving, with companies like Huajiang Technology and Longdu Tianren leading in the production of biodegradable materials [12][13] Future Prospects - The MIIT aims for non-grain bio-based materials to compete with fossil-based products in high-end sectors by 2025, indicating a strategic push towards advanced applications in aerospace and new energy [14][20] - New production lines utilizing alternative raw materials, such as reeds, are being established to meet the growing demand for biodegradable plastics [17][19]

Core Insights - The article discusses the recent advancements in non-grain bio-based materials and technologies, highlighting key innovations and applications in the industry [5][6]. Group 1: Key Technological Innovations - A total of 25 key technological innovations have been recognized, involving companies such as Shandong Elpai Powder, Ruijia Kang Biological, and Anhui Fengyuan Biological, among others [8]. - Notable innovations include the development of high-performance silicon-carbon anode materials from agricultural waste, which enhance battery capacity and lifespan [9]. - The creation of high-yield industrial strains for non-model organisms has been achieved, facilitating the production of bio-based materials from diverse non-grain biomass [10]. Group 2: Application Scenarios - Eight companies have been recognized for their application scenarios, including Shanghai Kaisa Biological and Weifang Xinlong Biological, focusing on the use of non-grain bio-based materials in various industries [35]. - Innovations in non-grain bio-based polyamide composites have led to a 20% weight reduction in refrigerated containers, demonstrating significant cost savings [35]. - The development of biodegradable PLA water bottles has been highlighted, showcasing the potential for environmentally friendly packaging solutions [38]. Group 3: Characteristic Clusters - Two development zones have been identified as characteristic clusters for non-grain bio-based materials, namely the Guizhen Economic Development Zone and the Nanle County Advanced Manufacturing Development Zone [43]. - These clusters focus on the comprehensive utilization of biomass resources, developing technologies for cellulose conversion and fermentation processes [44].

Core Viewpoint - The article emphasizes the importance of industrial biotechnology in supporting China's sustainable development and innovation in the bio-economy, focusing on key technologies and research areas that can replace fossil resources with renewable carbon resources and enhance industrial processes through modern biotechnology [5][20]. Group 1: Research Focus - The research institute focuses on three strategic themes: replacing fossil resources with renewable carbon resources, using clean biological processing instead of traditional chemical methods, and enhancing industrial levels through modern biotechnology [5]. - Key research areas include industrial protein science and biocatalysis engineering, synthetic biology and microbial manufacturing engineering, and biological systems and bioprocess engineering [5]. Group 2: Team Introduction - Zhang Yiheng, a prominent researcher and doctoral supervisor, leads the Low Carbon Synthesis Engineering Biology National Key Laboratory and has made significant contributions to the field, including the establishment of the in vitro BioTransformation (ivBT) engineering technology system [6]. - Zhang Yuzhen, another researcher, has developed microfluidic technologies for quantitative studies of microbial populations and is working on high-throughput identification techniques for important industrial enzymes [7][8]. Group 3: Recruitment Information - The institute is seeking to hire 2-3 postdoctoral research assistants and 1-2 assistant researchers, with a focus on candidates holding doctoral degrees in microbiology, molecular biology, or enzyme engineering [9][10]. - Competitive salaries and benefits are offered, including social insurance, housing funds, and opportunities for professional development and overseas visits [11][12]. Group 4: Career Development - Postdoctoral researchers can apply for permanent positions with competitive salaries and development opportunities, including potential advancement to senior technical roles based on their research achievements [13][14]. Group 5: Upcoming Events - The article mentions an upcoming forum on non-grain biomass high-value utilization, scheduled for January 27-29, 2025, in Hangzhou, focusing on clean pretreatment of biomass and commercialization of bio-based materials and fuels [20].

Core Viewpoint - The article discusses recent advancements in starch modification through the research conducted by the Tianjin Institute of Industrial Biotechnology, focusing on the enzyme Amylomaltase (AM) and its potential applications in addressing food security and carbon neutrality [5][6]. Group 1: Research Findings - The research team utilized large-scale molecular simulations and quantum mechanics/molecular mechanics (QM/MM) calculations to reveal the complete catalytic cycle of AM, identifying the rate-limiting steps in cycloamyloses (CA) synthesis [6][7]. - The study demonstrated that by strategically adjusting the polysaccharide chain transfer steps, several active mutant variants were obtained, enhancing enzyme performance primarily through reduced substrate transfer affinity [6][7]. - Mass spectrometry confirmed the generation of cycloamyloses with degrees of polymerization ranging from 22 to 61, validating theoretical predictions [6][7]. Group 2: Industrial Implications - The research provides a systematic molecular-level understanding of the biosynthesis process of CA, offering a clear engineering blueprint for the AM family, which could lead to more efficient and specific glycosyltransferases [6][7]. - The findings are significant for the industrial application of starch modification, contributing to the development of biobased materials and energy systems utilizing non-grain resources [9][11]. Group 3: Support and Collaboration - The research was supported by the Chinese Academy of Sciences' strategic pilot technology projects and the Tianjin Synthetic Biology Technology Innovation Capability Enhancement Action [7]. - Collaborations included contributions from various institutions, highlighting the interdisciplinary nature of the research [7].

Core Viewpoint - The seminar on efficient utilization of non-grain biomass resources was held in Harbin, focusing on the innovative development of the entire industrial chain of non-grain bio-based materials, emphasizing key technological innovations, application scenario expansion, and the cultivation of characteristic bases [1] Group 1: Industry Insights - Heilongjiang Province has abundant biomass resources, with crop straw production estimated at approximately 90 million tons and livestock manure generation around 110 million tons [1] - Notable examples of innovation in the non-grain bio-based materials industry include Heilongjiang Bioneng Green Energy Technology Group Co., Ltd., which produces green methanol from agricultural waste to generate biogas, and Daqing Shengquan Green Technology Co., Ltd., which develops and applies biochar products using biological solvent methods [1] Group 2: Event Objectives - The event aimed to gather the latest achievements and perspectives in the non-grain bio-based materials industry, outlining a blueprint for a comprehensive, multi-field, and deep-level technological and industrial cooperation system [1] - It provided a platform for face-to-face exchanges between Heilongjiang bio-based material companies and leading enterprises from outside the province, enhancing the coupling of bio-chemicals with traditional chemicals and the integration of industry and agriculture [1] - The goal is to effectively improve the collaborative innovation, scale production, and market penetration capabilities of the bio-based materials industry, accelerating its innovative development [1]